Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Biological Chemistry|July 14, 2016
Dipeptidyl peptidase 9 substrates and their discovery: current progress and the application of mass spectrometry-based approachesClaire H Wilson, Hui Emma Zhang, Mark D Gorrell, et al.
Journal of Diabetes|May 13, 2020
COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?Margaret F Bassendine, Simon H Bridge, Geoffrey W McCaughan, et al.
The FEBS Journal|February 15, 2011
Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-αFiona M Keane, Naveed A Nadvi, Tsun-Wen Yao, et al.
Plos One|February 4, 2017
Fibroblast activation protein is dispensable in the anti-influenza immune response in miceSioh-Yang Tan, Sumaiya Chowdhury, Natasa Polak, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 14, 2010
The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitisDetlef Schuppan, Mark D Gorrell, Thomas Klein, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2007
Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosisXiao X Huang, Geoffrey W McCaughan, Nicholas A Shackel, et al.
Hepatology (Baltimore, Md.)|September 22, 2005
Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell lineXin Maggie Wang, Denise Ming Tse Yu, Geoffrey W McCaughan, et al.
Central Nervous System Agents in Medicinal Chemistry|April 18, 2014
Homology modeling of human kynurenine aminotransferase III and observations on inhibitor binding using molecular dockingAlireza Nematollahi, William B Church, Naveed A Nadvi, et al.
Proteomics. Clinical Applications|January 29, 2014
Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapyElizabeth J Hamson, Fiona M Keane, Stefan Tholen, et al.
Pageof 11